<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab

Regeneron Announces Positive Phase II Results for Evinacumab

September 10, 2019

Regeneron Announces Positive Phase II Results for Evinacumab

In a trial evaluating patients with homozygous familial hypercholesterolemia, a genetically inherited form of increased LDL cholesterol, Regeneron’s drug showed a 49% decrease in LDL levels, compared with a 2% decrease for placebo. Yourway is dedicated to helping support clinical trials like this for rare disease patients.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?